None listed
Conditions
Brief summary
This study aims to assess the usability of a breathing platform for relaxation. Healthy participants will be used and required to fill in questionnaires during and at the completion of the study based on the ease of use of the system.
Interventions
The breathing platform will use a continuous positive air pressure (CPAP) device controlled by an app. Device and mobile phone (to run app) will be provided to participants by investigators on day 1 of the study. The device settings will include a pressure delivery between 4 and 20 cmH2O. Treatment session will involve starting their CPAP (with the 'on' button) and using the app for breathing instructions. Intended frequency of intervention involves 10-30 mins of therapy per day, for 4 days. Feedback & compliance will be logged in interview at day 5.
Sponsors
Study design
Eligibility
Inclusion criteria
• Participants are willing to give written, informed consent • Participants are healthy adults • Participants are able to comprehend and speak English • Participants are at least 18 years of age
Exclusion criteria
• Participants who are/may be pregnant or lactating • Participants that have a pre-existing lung disease/ condition that would predispose them to pneumothorax (for example: COPD; lung cancer; fibrosis of the lungs; recent (< 2years) case of pneumonia or lung infection; lung injury) • Participants who are unsuitable for the inclusion at the discretion of the investigator